This collection is the first systematic examination of the evolving relationship between the federal government and Canadian universities as revealed through changes in federal research and innovation policies.

In today’s business environment, as organizations constantly seek to growth and develop through the optimization of their innovative and creative potential, understanding the critical issues and management practices in R & D is essential. This book provides a critical revaluation of the state of the art issues and concepts in R&D management. The views expressed are those of leading French researchers and professionals in this field, fed by empirical studies in national and international firms.

Hopes are high that stem cell (SC) research will lead to treatments and cures for some of the most serious diseases affecting humankind today. SC science has been used in a treatment setting in the replacement of patients’ windpipes and in restoring sight to patients who were blind in one eye and in future it is hoped that when the body is injured it will be able to be stimulated to produce those types of SCs necessary to repair the particular damage caused. In the meantime, research into specific treatments for a wide range of serious conditions is being undertaken including Alzheimer’s disease, cancer, and diabetes. The book considers the regulatory governance of stem cell research, setting out a readily understandable account of the science and the challenges it poses for regulators as the research is increasingly being clinically applied. It provides a critical account of those elements of a regulatory system which will be required for any jurisdiction aiming to facilitate innovative and productive SC research while maintaining appropriate ethical and legal controls. The book addresses the specific failings in the current regulatory approach to SC research in the UK and goes on to look at the regulatory approaches in the US. The book systematically analyses the roles and responsibilities of the three key participants who collaborate in this process: regulators, scientists and tissue providers, arguing that a regulatory system which fails to recognise and facilitate the vital role which each of these three groups plays runs the risk of impairing the chances of the hopes for SC research being realised. The book places a particular emphasis on ensuring that those who contribute their bodily tissues to this endeavour are treated fairly, involving a recognition that their tissues are their property.

Although in recent years some emerging economies have improved their performance in terms of R&D investment, outputs and innovative capacity, these countries are still blighted by extreme poverty, inequality and social exclusion. Hence, emerging countries are exposed to conditions which differ quite substantially from the dominant OECD model of innovation policy for development and welfare. This Research Handbook contributes to the debate by looking at how innovation theory, policy and practice interact, and explains different types of configurations in countries that are characterized by two contrasting but mutually reinforcing features: systemic failure and resourcefulness. Focusing on innovation governance and public policies, it aims to understand related governance failures and to explore options for alternative, more efficient approaches.

Chinese enterprises have relied on importing technology and imitation as their main technology strategies in the past. Based on analysis of cross-countries' case studies and the history of industrial innovation, the authors proposed the concept of industry-driven basic research and expounds the important role of scientific discovery in industrial technological innovation. They are convinced that both the government and enterprises should focus on industry-driven basic research in order to bridge the gap between the government's target and what enterprises actually do in China. The challenge remains to be seen if China can transform Science and technology investment into real industrial innovation capability.

"This book is a reference guide to the theory and research supporting the field of Technology and Innovation Management"--Provided by publisher.

The UK has the potential to be world leader in innovation. The strength of UK universities and the wider knowledge base is a national asset being the most productive in the G8. But the challenges are great. To succeed in the global innovation economy, the UK must strengthen its ability to accelerate the commercialization of emerging technologies, and to capture the value chains linked to these. We have already made clear our commitment by maintaining the annual £4.6 billion budget for science and research programmes, with £150 million each year support university-business interaction. The UK's universities are increasingly collaborating with each other and with external organization to develop and commercialise knowledge, last year securing over £3 billion from external sources. This paper outlines a series of measures to make it easier for individuals, businesses and the public sector to innovate alone or in partnership. As part of a package of support the Government is relaunching the popular Smart brand and will increase the funding to the Technology Strategy Board. Research Councils UK will establish a principles-based framework for the treatment and submission of multi-institutional funding bids. Also the Government will continue to look for other ways to encourage more relationships between universities and business and will work with NESTA to establish a price centre to run, design and facilitate new inducement prices. The Government has also commissioned independent groups of academics and publishers to review the availability of published research, and to develop action plans for making this freely available. It will also create an Open Data Institute to develop semantic web technologies.

Bridge Maintenance, Safety, Management, Life-Cycle Sustainability and Innovations contains lectures and papers presented at the Tenth International Conference on Bridge Maintenance, Safety and Management (IABMAS 2020), held in Sapporo, Hokkaido, Japan, April 11–15, 2021. This volume consists of a book of extended abstracts and a USB card containing the full papers of 571 contributions presented at IABMAS 2020, including the T.Y. Lin Lecture, 9 Keynote Lectures, and 561 technical papers from 40 countries. The contributions presented at IABMAS 2020 deal with the state of the art as well as emerging concepts and innovative applications related to the main aspects of maintenance, safety, management, life-cycle sustainability and technological innovations of bridges. Major topics include: advanced bridge design, construction and maintenance approaches, safety, reliability and risk evaluation, life-cycle management, life-cycle sustainability, standardization, analytical models, bridge management systems, service life prediction, maintenance and management strategies, structural health monitoring, non-destructive testing and field testing, safety, resilience, robustness and redundancy, durability enhancement, repair and rehabilitation, fatigue and corrosion, extreme loads, and application of information and computer technology and artificial intelligence for bridges, among others. This volume provides both an up-to-date overview of the field of bridge engineering and significant contributions to the process of making more rational decisions on maintenance, safety, management, life-cycle sustainability and technological innovations of bridges for the purpose of enhancing the welfare of society. The Editors hope that these Proceedings will serve as a valuable reference to all concerned with bridge structure and infrastructure systems, including engineers, researchers, academics and students from all areas of bridge engineering.